This morning we received news of Mindset Pharma being sold to a big pharma player, Otsuka Pharmaceutical. The post Breaking News: Otsuka Pharmaceutical...
A PCT patent application from Terran Biosciences was just published covering their discovery of novel salts and polymorphs of the compound 4-OH-DiPT. The...
A PCT patent application from Terran Biosciences was just published covering their discovery of novel salts and polymorphs of the compound 4-OH-DiPT. The...
A PCT patent application from Terran Biosciences was just published covering their discovery of novel salts and polymorphs of the compound 4-OH-DiPT. The...
Terran Bioscience has filed a patent application for 4-OH-DiPT, adding another layer of patent intrigue around the lesser-known compound. The post Terran...
The first half of 2023 has come to an end, and so far, this year has been just as action-packed as 2022. The first two quarters...
Reunion Neuroscience is expected to go private later this year. The post Reunion Neuroscience Posts $48 Million Loss Ahead of Acquisition appeared first...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed The post News...
Mindset Pharma has been granted approval to start a Phase 2 trial for Major Depressive Disorder, using their lead drug candidate MSP-1014 The post Mindset...
Source: Stefan Quennevill 06/01/2023 "We continue to view Mindset as meaningfully undervalued," Stefan Quennevill reported in an Echelon Capital...